Aquilo Capital Management, LLC - PIERIS PHARMACEUTICALS INC ownership

PIERIS PHARMACEUTICALS INC's ticker is PIRS and the CUSIP is 720795103. A total of 73 filers reported holding PIERIS PHARMACEUTICALS INC in Q1 2022. The put-call ratio across all filers is 0.13 and the average weighting 0.1%.

Quarter-by-quarter ownership
Aquilo Capital Management, LLC ownership history of PIERIS PHARMACEUTICALS INC
ValueSharesWeighting
Q3 2023$984,351
+80.1%
3,303,1900.0%0.89%
+194.4%
Q2 2023$546,678
-87.7%
3,303,190
-27.4%
0.30%
-83.6%
Q1 2023$4,443,607
-6.2%
4,552,8760.0%1.84%
+3.5%
Q4 2022$4,734,991
+2.0%
4,552,876
+12.8%
1.78%
+6.3%
Q3 2022$4,642,000
-33.6%
4,036,280
+8.0%
1.67%
-29.8%
Q2 2022$6,987,000
-37.8%
3,736,280
+0.7%
2.38%
+44.3%
Q1 2022$11,238,000
-7.0%
3,708,882
+16.0%
1.65%
+20.6%
Q4 2021$12,083,000
-26.9%
3,196,5270.0%1.37%
-54.4%
Q3 2021$16,526,000
+35.0%
3,196,5270.0%3.00%
-5.6%
Q2 2021$12,243,000
+29.6%
3,196,527
-13.0%
3.18%
+86.4%
Q1 2021$9,446,000
+2.8%
3,675,5300.0%1.71%
-10.6%
Q4 2020$9,189,000
+20.8%
3,675,5300.0%1.91%
+137.3%
Q3 2020$7,608,000
-56.0%
3,675,530
-34.1%
0.80%
-76.9%
Q2 2020$17,284,000
+36.0%
5,575,5300.0%3.48%
-29.7%
Q1 2020$12,712,000
-28.5%
5,575,530
+12.3%
4.95%
-25.8%
Q4 2019$17,769,000
+76.1%
4,966,820
+67.9%
6.67%
-6.1%
Q3 2019$10,088,000
+47.8%
2,958,243
+103.8%
7.10%
+199.9%
Q2 2019$6,824,000
+68.2%
1,451,850
+19.9%
2.37%
+32.0%
Q1 2019$4,056,000
+25.9%
1,210,8370.0%1.80%
+15.1%
Q4 2018$3,221,0001,210,8371.56%
Other shareholders
PIERIS PHARMACEUTICALS INC shareholders Q1 2022
NameSharesValueWeighting ↓
Aquilo Capital Management, LLC 3,196,527$16,526,0003.00%
BVF INC/IL 5,328,239$27,547,0001.08%
Soleus Capital Management, L.P. 740,000$3,826,0000.60%
Cutter & CO Brokerage, Inc. 326,100$1,686,0000.40%
EAM Investors, LLC 288,459$1,491,0000.25%
PLATINUM INVESTMENT MANAGEMENT LTD 1,028,322$5,316,0000.15%
Rhenman & Partners Asset Management AB 300,000$1,551,0000.11%
Navis Wealth Advisors, LLC 16,000$83,0000.06%
Sigma Planning Corp 364,484$1,884,0000.06%
XTX Topco Ltd 32,650$169,0000.06%
View complete list of PIERIS PHARMACEUTICALS INC shareholders